Long-term performance of the Gleason score in predicting metastatic and fatal prostate cancer.
The time dependence in the performance of prognostic factors for cancer survival is typically incompletely understood, including in prostate cancer.
- 95% CI 1-3
APA
Lin Z, Stopsack KH, et al. (2026). Long-term performance of the Gleason score in predicting metastatic and fatal prostate cancer.. American journal of epidemiology, 195(4), 919-926. https://doi.org/10.1093/aje/kwaf080
MLA
Lin Z, et al.. "Long-term performance of the Gleason score in predicting metastatic and fatal prostate cancer.." American journal of epidemiology, vol. 195, no. 4, 2026, pp. 919-926.
PMID
40302103
Abstract
The time dependence in the performance of prognostic factors for cancer survival is typically incompletely understood, including in prostate cancer. We applied a "cumulative/dynamic" time-varying area under the curve (tAUC) for cumulative incidence of lethal prostate cancer (metastases/cancer-specific death). In two prospective prostate cancer patient cohorts followed for lethal outcomes after radical prostatectomy, genitourinary pathologists undertook a histopathologic review of tumor specimens to assign Gleason grade groups 1-5, a known strong short-term prognostic factor. Among 1490 patients, 144 lethal events occurred during 35 years of follow-up (median, 18). The 10-year risk of lethal disease was 2% (95% CI, 1-3) for grade group 2 and 21% (95% CI, 16-28) for grade group 5 cancers. By 25 years, risks were 5% (95% CI, 3-8) and 32% (95% CI, 26-41), respectively. Prediction accuracy was strongest over the first 10 years (tAUC 0.83 [95% CI, 0.79-0.86]) but remained informative for 25 years (tAUC 0.76 [95% CI, 0.70-0.81]), including among long-term metastasis-free survivors. Risk-based AUCs instead of hazard-based "incident/dynamic" AUCs allowed for interpretable characterization of prognostic accuracy over well-defined time periods. Lethal progression of high-grade prostate cancer occurred predominantly early, while that of lower grade tumors accumulated over decades after surgery.
MeSH Terms
Humans; Male; Prostatic Neoplasms; Neoplasm Grading; Middle Aged; Aged; Prostatectomy; Prospective Studies; Prognosis; Neoplasm Metastasis; Time Factors
같은 제1저자의 인용 많은 논문 (5)
- Apatinib and silver nanoparticles synergize against gastric cancer through the PI3K/Akt signaling pathway-mediated ferroptosis.
- Integrated bulk and single-cell transcriptomics with experimental validation to identify calmodulin-related prognostic genes in lung adenocarcinoma.
- Bibliometric analysis of research trends and collaboration patterns in cardio-oncology focusing on lung cancer and heart failure.
- Glypican-3-Targeted PET Imaging for Precise Diagnosis of Hepatocellular Carcinoma: From Bench to Bedside.
- Advancements in nanomedicine for the therapeutic regulation of efferocytosis: opportunities and challenges.